Skip to search formSkip to main contentSkip to account menu

6 ML RADIUM CHLORIDE RA-223 30 MCI/ML Injection [Xofigo]

Known as: Xofigo 1100 kBq/ML in 6 ML Injection, Xofigo (radium Ra-223 dichloride) 6600 kBq per 6 ML Injection, RADIUM RA-223 DICHLORIDE 30 uCi in 1 mL INTRAVENOUS INJECTION [Xofigo] 
National Institutes of Health

Related topics

Related topics

9 relations

Broader (2)

6 ML RADIUM CHLORIDE RA-223 30 MCI/ML InjectionRADIUM CHLORIDE RA-223 Injection [Xofigo]
Hydrochloric AcidInjectionRADIUM CHLORIDE RA-223Sodium Chloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Dicloruro de radio-223 (Xofigo®): aumento del riesgo de fallecimientos y fracturas
2015
2015
Anvisa aprova radiofármaco xofigo
A Anvisa aprovou o Xofigo® (radium 223) , para o tratamento de pacientes com câncer de prostata resistente a castracao (CPRC… 
2014
2014
Radium-223 dichloride (Xofigo®) for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease
In patients with advanced castration-resistant prostate cancer (CRPC), symptomatic bone metastases are frequently present. Xofigo…